tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Leukoplakia, Oral D007972 1 associated lipids
Peroneal Neuropathies D020427 1 associated lipids
Poxviridae Infections D011213 1 associated lipids
Kaposi Varicelliform Eruption D007617 1 associated lipids
Lacerations D022125 1 associated lipids
Megacolon, Toxic D008532 1 associated lipids
Hepatitis, Autoimmune D019693 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Wiederrecht GJ et al. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells. 1995 Prog Cell Cycle Res pmid:9552353
Arreaza G et al. Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. 1995 J. Clin. Endocrinol. Metab. pmid:8530625
Fruman DA et al. The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells. 1995 J. Immunol. pmid:7530743
Neuhaus P et al. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. 1995 Transplantation pmid:7530868
Heeckt PF et al. Functional impairment of enteric smooth muscle and nerves caused by chronic intestinal allograft rejection regresses after FK506 rescue. 1995 Transplantation pmid:7530870
Gruessner RW et al. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. 1995 Transplantation pmid:7530871
Todo S et al. Abdominal multivisceral transplantation. 1995 Transplantation pmid:7530873
Hamasaki Y et al. Inhibition of leukotriene production by FK506 in rat basophilic leukemia-1 cells. 1995 Pharmacology pmid:7538218
Ning YM and Sanchez ER Stabilization in vitro of the untransformed glucocorticoid receptor complex of S49 lymphocytes by the immunophilin ligand FK506. 1995 J. Steroid Biochem. Mol. Biol. pmid:7532989
Fruman DA et al. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells. 1995 Eur. J. Immunol. pmid:7533090
Cameron AM et al. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7533300
Shapiro R et al. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. 1995 Transplantation pmid:7533343
Cox KL et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. 1995 Transplantation pmid:7533344
McDiarmid SV et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. 1995 Transplantation pmid:7533345
Jain AB et al. One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. 1995 Transplant. Proc. pmid:7533353
Rucay P et al. FK 506 as treatment of late acute rejection in liver transplant patients. 1995 Transplant. Proc. pmid:7533354
Grobecker HF et al. Cyclosporine A-induced hypertension in SHR and WKY: role of the sympatho-adrenal system. 1995 Clin Exp Pharmacol Physiol Suppl pmid:9072458
Watanabe K et al. Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. 1995 Transplant. Proc. pmid:7533389
Wennberg L et al. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection. 1995 Transplant. Proc. pmid:7533391
Tanaka M et al. Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation. 1995 Transplant. Proc. pmid:7533392
Tsugita M et al. Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. 1995 Transplant. Proc. pmid:7533393
Sakimoto H et al. Prolonged survival of hamster-to-rat pancreas xenografts by FK 506 and splenectomy. 1995 Transplant. Proc. pmid:7533394
Celli S et al. Mechanisms of protection from humoral rejection by a xenografted liver. 1995 Transplant. Proc. pmid:7533395
Kuroki H and Ikuta Y Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survivals treated by short course of FK 506 or cyclosporine. 1995 Transplant. Proc. pmid:7533405
Ko S et al. Significance of newly developed liposomal FK 506 in canine liver transplantation. 1995 Transplant. Proc. pmid:7533406
Fukuzaki T et al. Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. 1995 Transplant. Proc. pmid:7533407
Gregory CR et al. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. 1995 Transplantation pmid:7533955
Egawa H et al. Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. 1995 Transplantation pmid:7533958
Molenaar JC [Transplantation of the small intestine]. 1995 Ned Tijdschr Geneeskd pmid:7534380
Swenson JM et al. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506. 1995 J. Am. Coll. Cardiol. pmid:7534779
Hodgkiss JP and Kelly JS Only 'de novo' long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex. 1995 Brain Res. pmid:8821755
Thomson AW and Bonham CA Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection. 1995 Adv. Exp. Med. Biol. pmid:7572394
Paterson JM et al. Control of a novel adenylyl cyclase by calcineurin. 1995 Biochem. Biophys. Res. Commun. pmid:7575502
Cunningham EB The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin. 1995 Biochem. Biophys. Res. Commun. pmid:7575593
Ellis D Clinical use of tacrolimus (FK-506) in infants and children with renal transplants. 1995 Pediatr. Nephrol. pmid:7577418
Masaki Y et al. Cellular basis of acquired immunologic tolerance following total bowel transplantation in rats. I. Relation between donor lymphocyte chimerism and host-cell-mediated immunity. 1995 Transplant. Proc. pmid:7536971
Furuke K et al. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control. 1995 Int. Immunol. pmid:7577807
Masaki Y et al. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts. 1995 Transplant. Proc. pmid:7536972
Suzuki H et al. Spleen grafting might induce transplantation tolerance in rats. 1995 Transplant. Proc. pmid:7536973
Shapiro R et al. FK506 in pediatric kidney transplantation--primary and rescue experience. 1995 Pediatr. Nephrol. pmid:7492486
Mehta BA et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. 1995 Blood pmid:7579455
Ito A et al. Induction of tolerance in rat cardiac allograft model by intrathymic injection of donor bone marrow cells. 1995 Transplant. Proc. pmid:7536974
Coss MC et al. Molecular cloning, DNA sequence analysis, and biochemical characterization of a novel 65-kDa FK506-binding protein (FKBP65). 1995 J. Biol. Chem. pmid:7493967
Hemenway C FK506 in bone marrow transplantation. 1995 Blood pmid:7579473
Büttemeyer R et al. Peripheral nerve allotransplant immunosuppressed with FK 506: preliminary results. 1995 Transplant. Proc. pmid:7536979
Lee MJ et al. Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats. 1995 Pharm. Res. pmid:7494802
Venkataramanan R et al. Clinical pharmacokinetics of tacrolimus. 1995 Clin Pharmacokinet pmid:8787947
Arita S et al. Effect of FK 506 in experimental pancreas transplantation. 1995 Transplant. Proc. pmid:7536980
Zhao Y and Iwata M Cross-linking of the TCR-CD3 complex with CD4, CD8 or LFA-1 induces an anti-apoptotic signal in thymocytes: the signal is canceled by FK506. 1995 Int. Immunol. pmid:7495746
Aono T et al. Minimal threshold of FK 506 for enhancing liver regeneration in thymectomized rats. 1995 Transplant. Proc. pmid:7536981
Saito T et al. In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. 1995 FEBS Lett. pmid:7498550
Iwabuchi T et al. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth. 1995 J. Dermatol. Sci. pmid:7537082
Yamamoto S et al. Cross-species transplantation of photoreceptors with tacrolimus hydrate (FK506) treatment. 1995 Jpn. J. Ophthalmol. pmid:8926639
Freeman DJ et al. Stability of FK 506 in whole blood samples. 1995 Ther Drug Monit pmid:7542810
Strumph P et al. The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. 1995 Transplantation pmid:7542815
Sihra TS et al. A role for calcineurin (protein phosphatase-2B) in the regulation of glutamate release. 1995 Biochem. Biophys. Res. Commun. pmid:7542882
Dumont FJ et al. Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma. 1995 Exp. Cell Res. pmid:7543051
Zhao Y et al. Calcineurin activation protects T cells from glucocorticoid-induced apoptosis. 1995 J. Immunol. pmid:7539018
Corey HE et al. Renal allograft rejection in children and young adults: the Banff classification. 1995 Pediatr. Nephrol. pmid:7543274
Bronsther O et al. Liver transplantation for HBV-related disease under immunosuppression with tacrolimus: an experience with 78 consecutive cases. 1995 J Okla State Med Assoc pmid:7539077
Griffith JP et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. 1995 Cell pmid:7543369
Chen J et al. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7539137
Prud'homme GJ et al. Effects of cyclosporin A, rapamycin, and FK520 on peripheral T-cell deletion and anergy. 1995 Cell. Immunol. pmid:7543371
Renoir JM et al. Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7539138
Migita K et al. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. 1995 J. Clin. Invest. pmid:7543492
Rodriguez Rilo HL et al. Rapid hair regrowth in refractory alopecia universalis associated with autoimmune disease following liver transplantation and tacrolimus (FK506) therapy. 1995 Transplantation pmid:7539169
Schleibner S et al. FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week results. 1995 Transpl. Int. pmid:7539270
Ko S et al. The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. 1995 Transplantation pmid:7539553
Fealy MJ et al. Association of down-regulation of cytokine activity with rat hind limb allograft survival. 1995 Transplantation pmid:7539555
Sher LS and Makowka L Immunosuppression: now we have choices. 1995 Hepatology pmid:7544759
Perrot-Applanat M et al. The 59 kDa FK506-binding protein, a 90 kDa heat shock protein binding immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus. 1995 J. Cell. Sci. pmid:7544801
Hibi S et al. Severe rhabdomyolysis associated with tacrolimus. 1995 Lancet pmid:7544861
Kinoshita I et al. Myoblast allotransplantation in primates. 1995 Muscle Nerve pmid:7544871
Rao PN et al. Reduction of FK-506 requirements by combination with polyethylene glycol superoxide dismutase in orthotopic rat liver transplantation. 1995 J. Allergy Clin. Immunol. pmid:7541060
Monsour HP et al. Renal insufficiency and hypertension as long-term complications in liver transplantation. 1995 Semin. Liver Dis. pmid:7544917
Gold BG et al. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. 1995 J. Neurosci. pmid:7472502
Varela E [Small bowel transplantation]. 1995 Acta Gastroenterol. Latinoam. pmid:7544939
Takahara S and Okuyama A [Blood level monitoring of immunosuppressive agent]. 1995 Rinsho Byori pmid:7474422
Taler SJ et al. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. 1995 Am. J. Hypertens. pmid:7544983
Morris RE and Brown BW Tacrolimus for prevention of liver allograft rejection: clinical trials and tribulations. 1995 Lancet pmid:7475764
Starzl TE et al. Randomised trialomania? The multicentre liver transplant trials of tacrolimus. 1995 Lancet pmid:7475777
Milad M et al. Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. 1995 Mol. Endocrinol. pmid:7476967
Zhang J and Steiner JP Nitric oxide synthase, immunophilins and poly(ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. 1995 Neurol. Res. pmid:7477744
Jindal RM and Popescu I Renal dysfunction associated with liver transplantation. 1995 Postgrad Med J pmid:7479462
Zhu D et al. Myristoylation of calcineurin B is not required for function or interaction with immunophilin-immunosuppressant complexes in the yeast Saccharomyces cerevisiae. 1995 J. Biol. Chem. pmid:7559604
Stemmer PM et al. Factors responsible for the Ca(2+)-dependent inactivation of calcineurin in brain. 1995 FEBS Lett. pmid:7589543
Hadad SJ et al. FK 506: effects on glomerular hemodynamics and on mesangial cells in culture. 1995 Kidney Int. pmid:7564092
Mazur P et al. Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase. 1995 Mol. Cell. Biol. pmid:7565718
Ockenfels HM et al. Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. 1995 Dermatology (Basel) pmid:8534940
Spencer DM et al. A general strategy for producing conditional alleles of Src-like tyrosine kinases. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7568222
Orengo CA et al. Structural similarity between the pleckstrin homology domain and verotoxin: the problem of measuring and evaluating structural similarity. 1995 Protein Sci. pmid:8535234
Holsinger LJ et al. Signal transduction in T lymphocytes using a conditional allele of Sos. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7568223
Ihara H et al. Intra- and interindividual variation in the pharmacokinetics of tacrolimus (FK506) in kidney transplant recipients--importance of trough level as a practical indicator. 1995 Int. J. Urol. pmid:8536129
Vilquin JT et al. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. 1995 Hum. Gene Ther. pmid:8573612
Sano T et al. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma. 1995 Eur. Respir. J. pmid:8575571
Faerman CH and Karplus PA Consensus preferred hydration sites in six FKBP12-drug complexes. 1995 Proteins pmid:8539241
Groth CG Immunosuppressive regimens of tomorrow. 1995 Transplant. Proc. pmid:8539797
Sekigawa I et al. Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. 1995 J. Clin. Immunol. pmid:8576317
Hariharan S et al. Conversion from cyclosporine to tacrolimus after pancreas transplantation. 1995 Transplant. Proc. pmid:8539799
Henley SE et al. Lipids following pancreas transplantation in recipients receiving FK 506. 1995 Transplant. Proc. pmid:8539809